We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

PoliSCI (w/e 09 April 2020)

PoliSCI

Your weekly digest of policy news, funding competitions, and calls for evidence.

What’s been in the news?
 European Commission flags

Member States to boost supply and availability of medicines

The EU Commission is urging members to ensure that European citizens have access to medicines during the pandemic. Disruption to the medicine supply chain, led the commission to release guidelines on the rational supply, allocation and use of essential medicines to treat patients. The guidelines should be followed by EU nations in order to ensure supply increases and production is maintained. 

Commissioner Stella Kyriakides, head of Health and Food Safety, said ‘We are presenting concrete actions to Member States to proactively prevent shortages and ensure that our hospitals have the essential medicines needed to save lives. I call on the solidarity and responsibility of the EU pharmaceutical industry to increase the production of medicines needed to treat seriously ill coronavirus patients.’



 Stethoscope and world map

Green finance will be the key focus post coronavirus  

The EU promises to create a more sustainable economy in the recovery phase of the virus. The European Commission hopes to adopt 'The Renewed Sustainable Finance Strategy’ towards the latter part of 2020, which aims to accelerate green investments.

This strategy will play a critical role in ensuring that the recovery is in line with the vision set out under the European Green Deal. 

Valdis Dombrovskis, the EU Commission’s executive vice-president, head of the economy, said ‘We are currently battling the coronavirus outbreak, but we must not lose sight of our long-term sustainability objectives, including making Europe climate-neutral by 2050.’


Coronavirus vaccine

COVID-19: Roundup 

As Covid-19 continues to spread across the globe, we round up some of the innovative steps being taken by businesses in the pharmaceutical and chemical sector to aid those on the frontline of this global crisis.

Read more here. 

 

 

 

 

Calls for evidence

Deadline: 24 April 2020


Deadline: 01 May 2020


Deadline: 30 April 2020

Funding competitions


Apply for a share of £20 million which has been made available for novel coronavirus research  


Deadline: 22 April 2020

Apply for a share of up to £25 million to deliver ambitious or disruptive R&D innovations.


Deadline: 01 July 2020

Applicants are invited to spend up to 36 months (full or part time) on secondment in the biomedical sciences sector.


Deadline: 13 May 2020

Apply for funding in innovation projects across 3 streams. 


Deadline: 28 April 2020

Share this article